Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension
- PMID: 1666421
- DOI: 10.1254/jjp.57.571
Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension
Abstract
To estimate the participation of a Na+,K(+)-ATPase-inhibiting plasma factor in pregnancy induced hypertension (PIH), the inhibitory activity and the characteristics of plasma extract eluted with ethanol through a C8 column were examined in normotensive non-pregnant women (N) and women with normal pregnancy (NP) and PIH. There were no differences among the 3 groups in the Na+,K(+)-ATPase activity of erythrocyte ghosts. The heat- and acid-stable plasma extract dose-dependently inhibited Na+,K(+)-ATPase activity with a pattern similar to that of ouabain, but different from that of vanadate. The inhibitory activity of plasma extract was not influenced by polyclonal digoxin antibody which almost completely prevented digoxin-induced inhibition and slightly but significantly reduced the ouabain-induced one. The results indicate that the plasma extract has ouabain-like inhibitory activity on Na+,K(+)-ATPase and that it is not endogenously synthesized digoxin itself, but a substance differing in structure from digoxin. Furthermore, the ouabain-like Na+,K(+)-ATPase inhibitory activity in NP plasma was significantly lower than that in PIH plasma, which was similar to that in N plasma. There were significant relationships between the ouabain-like Na+,K(+)-ATPase inhibitory activities in plasma and the diastolic and systolic blood pressures in NP and PIH groups. The results suggest that the lower ouabain-like Na+,K(+)-ATPase inhibitory activity in plasma probably participates in maintaining the blood pressure within the normal range during pregnancy and its failure may be involved in the genesis of PIH.
Similar articles
-
Serum digoxin-like substances in pregnancy-induced hypertension.Clin Sci (Lond). 1989 Aug;77(2):189-94. doi: 10.1042/cs0770189. Clin Sci (Lond). 1989. PMID: 2548800
-
Endogenous inhibition of red blood cell Na,K-ATPase in essential and pregnancy-induced hypertension.Clin Exp Hypertens A. 1989;11(4):587-601. doi: 10.3109/10641968909035362. Clin Exp Hypertens A. 1989. PMID: 2551544
-
A study of erythrocyte membrane cation transport adenosine triphosphatases in pregnancy-induced hypertension and of in vivo effects of diuretic treatment.Clin Chim Acta. 1981 Feb 19;110(1):27-33. doi: 10.1016/0009-8981(81)90296-5. Clin Chim Acta. 1981. PMID: 6111403
-
Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.Clin Exp Hypertens. 1998 Jul-Aug;20(5-6):499-508. doi: 10.3109/10641969809053228. Clin Exp Hypertens. 1998. PMID: 9682906 Review.
-
Digoxin and its Na+/K+-ATPase-targeted actions on cardiovascular diseases and cancer.Bioorg Med Chem. 2024 Nov 15;114:117939. doi: 10.1016/j.bmc.2024.117939. Epub 2024 Oct 5. Bioorg Med Chem. 2024. PMID: 39396465 Review.
Cited by
-
Fluoride Exposure Induces Inhibition of Sodium-and Potassium-Activated Adenosine Triphosphatase (Na+, K+-ATPase) Enzyme Activity: Molecular Mechanisms and Implications for Public Health.Int J Environ Res Public Health. 2019 Apr 21;16(8):1427. doi: 10.3390/ijerph16081427. Int J Environ Res Public Health. 2019. PMID: 31010095 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous